PARK7 and breast cancer: Our results revealed that DJ-1 might play different roles in different breast cancer subtypes, suggesting that DJ-1 may be a specific marker for HR+ breast cancer, which providing a theoretical basis for further study of the heterogeneity between different subtypes.